Please assess the completion status of the following clinical trial:

Trial Title: Ultraviolet Light Exposure and Immunosuppression in Cutaneous Melanoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Resident of New Mexico~* Age between the 1 and 95~* Newly diagnosed with cutaneous invasive melanoma; any stage permitted (ICDO C44.0-9) between September 1, 2008 and December 31, 2011.~* SSM (superficial spreading melanoma) and NM (nodular melanoma) histological subtypes are allowed~* Access to a telephone or be able to participate in a personal interview at the clinic~* Physically and mentally competent to complete a 1-hour telephone or personal interview~Exclusion Criteria:~* Ocular melanoma, LMM (lentigo maligna melanoma) or ALM (acral lentigo melanoma), and mucosal melanoma cases.~* No access to a telephone or is not able to meet with the interviewer.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 95 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).